- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PET sales drive ADAC’s 3Q revenue increase
ADAC Laboratories parlayed expansion of its distribution agreement with Hitachi in Japan and a three-year group purchasing agreement with Novation signed during the third quarter of fiscal 2000 into a net income of $4.6 million, compared to a net loss
ADAC Laboratories parlayed expansion of its distribution agreement with Hitachi in Japan and a three-year group purchasing agreement with Novation signed during the third quarter of fiscal 2000 into a net income of $4.6 million, compared to a net loss for the third quarter of 1999 of $5.4 million.
The Novation contract is expected to result in purchases of $15 million in PET and nuclear medicine imaging equipment during the first year of the deal.
Texas-based Novation is the healthcare industrys largest purchasing organization. The ADAC contract was the result of competitive public bids.
Hitachi Medical Systems is now ADACs exclusive distributor in Japan of its PET imaging systems, as well as its nuclear medicine products and its radiation therapy planning system.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
